Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients. [electronic resource]
- Osteoarthritis and cartilage 06 2017
- 866-877 p. digital
Publication Type: Journal Article
1522-9653
10.1016/j.joca.2017.01.006 doi
Adaptor Proteins, Signal Transducing Adult Aged Aged, 80 and over Analgesics--therapeutic use Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee Biomarkers--blood Bone Morphogenetic Proteins--blood C-Reactive Protein--metabolism Cartilage Oligomeric Matrix Protein--blood Collagen Type I--blood Collagen Type II--blood Collagen Type III--blood Disease Progression Female Genetic Markers Humans Intercellular Signaling Peptides and Proteins--blood Interleukin-6--blood Logistic Models Male Matrix Metalloproteinase 9--blood Middle Aged Osteoarthritis, Hip--blood Osteoarthritis, Knee--blood Osteocalcin--blood Peptide Fragments--blood Peptides--blood Procollagen--blood Prognosis Propensity Score Vascular Endothelial Growth Factor A--blood